J&J’s OTTAVA FDA Win and Talc Settlement: What’s Next?
Johnson & Johnson (JNJ) is betting its future on a strategic pivot toward innovative medicines and MedTech, aiming to neutralize patent expirations and litigation headwinds through the recent FDA De…
